News

a federal judge has remanded the case filed by Nevada against Kalshi and Polymarket's parent company Blockratize to state court, ruling that the relevant claims are mainly based on state law and that the Commodity Exchange Act does not completely preempt state law claims. This move means that Nevada regulators can continue to seek a temporary injunction in state court, increasing the risk that Kalshi and Polymarket will be restricted from offering event contract trading locally. The report states that Kalshi is evaluating emergency appeal options, and Polymarket has applied for a stay of enforcement. Previously, Nevada accused that the relevant event contracts require licensing under state law and filed a lawsuit.

Odaily reported that Ronin has released an economic model adjustment plan. As the network is expected to transition to Layer2 by the end of March, passive staking rewards and the original validator system will be cancelled. Instead, a "Proof of Allocation" mechanism will be adopted, providing targeted incentives to builders who make actual contributions to the ecosystem. The announcement also stated that the Ronin Treasury will strengthen its financial position by increasing RoninMarket trading commissions, sequencer revenues, and new income sources such as ecosystem applications and game tokens. In terms of governance, control of the treasury will shift from validators to a voting mechanism based on RON token weight, which will be used to review buybacks, investments, and DeFi-related activities.

The institution has also significantly reduced its target share price from $19 per share to $16.5 per share, a decrease of 13.2%. This rating adjustment reflects analysts' cautious attitude toward the company's short-term performance outlook. Although Select Medical maintains a leading position as a specialized medical service provider in the fields of rehabilitation hospitals and specialty outpatient clinics, current operational cost pressures and changes in the policy environment within the healthcare industry may pose challenges to its profit growth. The downward adjustment of the target price indicates that analysts have reassessed the company's valuation level. The new target price of $16.5 still offers upside potential compared to the current share price, but it is noticeably closer to previous expectations, which may suggest that institutional investors hold a more conservative outlook on its future growth pace.